The use of positron-emission tomography in the diagnosis of tumour phenotype

BJU International, Supplement

Volumn 101, Issue SUPPL.4, 2008, Pages 36-38

  Divgi, Chaitanya ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE IX; FLUORODEOXYGLUCOSE F 18; IODINE 124; MONOCLONAL ANTIBODY G250; PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN; CA9 PROTEIN, HUMAN; CARBONATE DEHYDRATASE;

AUTORADIOGRAPHY; CANCER SURGERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG ACCUMULATION; DRUG UPTAKE; HUMAN; ISOTOPE LABELING; KIDNEY CARCINOMA; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; TREATMENT RESPONSE; ENZYMOLOGY; GENETICS; KIDNEY TUMOR; METABOLISM; REVIEW; SCINTISCANNING;

ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

EID: 44449147064     PISSN: 14655101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (20)

1. Warburg O, Posener K, Negelein E. Ueber den Stoffwechsel tumoren. Biochem Z 1924; 152:319-344
2. Kim JW, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 2006; 66:8927-8930
3. Juweid ME, Stroobants S, Hoekstra OS et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25: 571-578 (Pubitemid 350002965)
4. Juweid ME, Cheson BD. Positronemission tomography and assessment of cancer therapy. N Engl J Med 2006; 354: 496-507 (Pubitemid 43200300)
5. Powles T, Murray I, Brock C, Oliver T, Avril N. Molecular positron emission tomography and PET/CT imaging in urological malignancies. Eur Urol 2007; 51: 1511-1521 (Pubitemid 46634756)
6. Plas DR, Thompson CB. Akt-dependent transformation: there is more to growth than just surviving. Oncogene 2005; 24: 7435-7442 (Pubitemid 41637983)
7. Buck AK, Bommer M, Stilgenbauer S et al. Molecular imaging of proliferation in malignant lymphoma. Cancer Res 2006; 66: 11055-11061 (Pubitemid 44877006)
8. Glunde K, Jacobs MA, Bhujwalla ZM. Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev Mol Diagn 2006; 6: 821-829 (Pubitemid 44903998)
9. Skinnider BF, Amin MB. An immunohistochemical approach to the differential diagnosis of renal tumors. Semin Diagn Pathol 2005; 22: 51-68 (Pubitemid 43163179)
10. Carlson RW, Moench SJ, Hammond ME et al. HER2 testing in breast cancer: NCCN Task Force report and recommendations. J Natl Compr Cane Netw 2006; 4 (Suppl. 3): S1-22
11. Lawrentschuk N, Davis ID, Bolton DM, Scott AM. Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship. BJU Int 2006; 97:916-922
12. US Food and Drug Administration. Product Approval Information. Available at: http://www.fda.gov/cder/biologics/products/capcyt102896.htm. Accessed March 2008
13. Wikipedia. lodine-124. Available at: http://en.wikipedia.org/wiki/lodine- 124 or http://nucleardata.nuclear.lu.se. Accessed March 2008
14. 131l-labeled chimeric G250 in metastatic renal cancer. J Nucl Med 2004; 45: 1412-1421
15. Oosterwijk E, Divgi CR, Brouwers A et al. Monoclonal antibody-based therapy for renal cell carcinoma. Urol Clin North Am 2003; 30: 623-631
16. Huang WC, Kagiwada MA, Russo P. Surgery insight: advances in techniques for open partial nephrectomy. Nat Clin Pract Urol 2007; 4: 444-450
17. Sorbellini M, Kattan MW, Snyder ME et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005; 173: 48-51 (Pubitemid 39627669)
18. 124I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol 2007; 8: 304-310
19. Trastour C, Benizri E, Ettore F et al. HIF1α and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Int J Cancer 2007; 120: 1451-1458 (Pubitemid 46355379)
20. Winter SC, Buffa FM, Silva P et al. Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers. Cancer Res 2007; 67: 3441-3449